Levocetirizina Tolife

Levocetirizine dihydrochloride, the active ingredient in Levocetirizina Tolife, is a second‑generation H1 receptor antagonist presented as an oral dosage form for systemic use. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in adults and adolescents.

GNH USA supplies Levocetirizina Tolife as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine dihydrochloride acts on peripheral H1‑histamine receptors to control allergic disease manifestations.

- Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Seasonal allergic rhinitis: alleviates symptoms triggered by pollen or outdoor allergens. - Chronic idiopathic urticaria: diminishes hives and associated itching, improving quality of life.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Drowsiness or fatigue: may affect alertness, especially at the start of therapy. - Dry mouth: transient sensation of oral dryness. - Altered taste perception: temporary metallic or bitter taste.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat requiring urgent care. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Anaphylactic reaction: rapid onset of systemic hypersensitivity needing immediate medical intervention.

Before initiating levocetirizine therapy, consider the following safety measures.

- Renal function assessment: dose adjustment may be needed in severe renal impairment. - Concomitant CNS depressants: use caution as additive sedation can occur. - Elderly patients: monitor for increased sensitivity to drowsiness. - Known hypersensitivity: avoid if the patient has previously reacted to levocetirizine or related antihistamines. - Pregnancy and lactation: consult a healthcare professional; benefits must outweigh potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levocetirizine may interact with other medicines; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): can raise levocetirizine plasma levels. - Erythromycin or clarithromycin: may increase exposure and risk of side effects. - Other H1‑antihistamines: additive antihistaminic effects may lead to excessive sedation.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance drowsiness and impair coordination. - CNS depressants (e.g., benzodiazepines, opioids): monitor for heightened sedation. - Theophylline: may experience altered theophylline metabolism; observe therapeutic response.